Skip to main content

Table 2 Characteristics of the PredicinePLUS™ platform and detected alterations

From: Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

Cohort

 Total cases

49

 Cases included in final analyses

40

Regions analyzed

180 genes

Panel size

565 kb

Samples with detectable alterations

40/43 (93%)

Number of genomic alterations

 Mean

6.7

 Median

6.0

 Range

1–22

Number of genes with detected alterations

57

Variant allele frequency of detected alterations

0.11–68.6%

Commonly detected SNV/indels

TP53, PTEN, PIK3CA, ATM, ESR1

Commonly detected copy number amplifications

MYC, CCND1, PIK3CA

Commonly detected copy number losses

BRCA1, CDKN2A, ATM

  1. SNV single nucleotide variant, Indels insertion-deletion mutations